Biogen Inc to Discuss the Approval of ADUHELM Call Transcript - Thomson StreetEvents

Biogen Inc to Discuss the Approval of ADUHELM Call Transcript

Biogen Inc to Discuss the Approval of ADUHELM Call Transcript - Thomson StreetEvents
Biogen Inc to Discuss the Approval of ADUHELM Call Transcript
Published Jun 08, 2021
Published Jun 08, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of BIIB.OQ conference call or presentation 8-Jun-21 12:00pm GMT

  
Report Type:

Transcript

Source:
Company:
Biogen Inc
Ticker
BIIB.OQ
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Biogen Inc Investor Day Transcript – 2021-09-21 – US$ 54.00 – Edited Transcript of BIIB.OQ corporate analyst meeting</ 21-Sep-21 2:00pm GMT

Biogen Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2021-09-09 – US$ 54.00 – Edited Transcript of BIIB.OQ presentation 9-Sep-21 1:30pm GMT

Biogen Inc Q2 2021 Earnings Call Summary – 2021-07-22 – US$ 54.00 – Edited Brief of BIIB.OQ earnings conference call or presentation 22-Jul-21 12:00pm GMT

Biogen Inc Q2 2021 Earnings Call Transcript – 2021-07-22 – US$ 54.00 – Edited Transcript of BIIB.OQ earnings conference call or presentation 22-Jul-21 12:00pm GMT

Biogen Inc at SVB Leerink CNS Forum (Virtual) Transcript – 2021-06-29 – US$ 54.00 – Edited Transcript of BIIB.OQ presentation 29-Jun-21 5:50pm GMT

Biogen Inc Annual Shareholders Meeting Transcript – 2021-06-02 – US$ 54.00 – Edited Transcript of BIIB.OQ shareholder or annual meeting 2-Jun-21 1:00pm GMT

Biogen Inc Q1 2021 Earnings Call Summary – 2021-04-22 – US$ 54.00 – Edited Brief of BIIB.OQ earnings conference call or presentation 22-Apr-21 12:00pm GMT

Biogen Inc Q1 2021 Earnings Call Transcript – 2021-04-22 – US$ 54.00 – Edited Transcript of BIIB.OQ earnings conference call or presentation 22-Apr-21 12:00pm GMT

Biogen Inc at the Stifel 3rd Annual CNS Day Transcript – 2021-03-31 – US$ 54.00 – Edited Transcript of BIIB.OQ presentation 31-Mar-21 4:00pm GMT

Biogen Inc Evaluation Of Aducanumab Efficacy And Safety In Early Alzheimer's Disease Discussion at AD/PD Conference Call Transcript – 2021-03-13 – US$ 54.00 – Edited Transcript of BIIB.OQ conference call or presentation 13-Mar-21 11:45am GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Biogen Inc to Discuss the Approval of ADUHELM Call Transcript" Jun 08, 2021. Alacra Store. May 23, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Biogen-Inc-to-Discuss-the-Approval-of-ADUHELM-Call-T14839019>
  
APA:
Thomson StreetEvents. (2021). Biogen Inc to Discuss the Approval of ADUHELM Call Transcript Jun 08, 2021. New York, NY: Alacra Store. Retrieved May 23, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Biogen-Inc-to-Discuss-the-Approval-of-ADUHELM-Call-T14839019>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.